Back to mobile site

GE HealthCare to buy SOFIE Biosciences for $945M in cash

October 5, 2026 8:00 AM EDT Send to a Friend
GE HealthCare (Nasdaq: GEHC) has agreed to acquire SOFIE Biosciences, a U.S.-based contract manufacturing organization (CMO) for positron emission tomography ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login